122 related articles for article (PubMed ID: 38360208)
21. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
[No Abstract] [Full Text] [Related]
22. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas.
Lee M; Kalani MY; Cheshier S; Gibbs IC; Adler JR; Chang SD
Neurosurg Focus; 2008; 24(5):E4. PubMed ID: 18447743
[TBL] [Abstract][Full Text] [Related]
23. Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series.
Rutenberg MS; Holtzman AL; Indelicato DJ; Huh S; Rao D; Fiester PJ; Morris CG; Tavanaiepour D; Amdur RJ
J Neurooncol; 2022 May; 157(3):425-433. PubMed ID: 35278157
[TBL] [Abstract][Full Text] [Related]
24. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience.
Lee CC; Yang HC; Chen CJ; Hung YC; Wu HM; Shiau CY; Guo WY; Pan DH; Chung WY; Liu KD
J Neurosurg; 2014 Dec; 121 Suppl():167-78. PubMed ID: 25434950
[TBL] [Abstract][Full Text] [Related]
25. Effects of Surgery and Proton Therapy on Cerebral White Matter of Craniopharyngioma Patients.
Uh J; Merchant TE; Li Y; Li X; Sabin ND; Indelicato DJ; Ogg RJ; Boop FA; Jane JA; Hua C
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):64-71. PubMed ID: 26279025
[TBL] [Abstract][Full Text] [Related]
26. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
Beltran C; Roca M; Merchant TE
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium.
Blackburn TP; Doughty D; Plowman PN
Br J Neurosurg; 1999 Aug; 13(4):359-65. PubMed ID: 10616561
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy alone for pediatric patients with craniopharyngioma.
Young M; Delaney A; Jurbergs N; Pan H; Wang F; Boop FA; Merchant TE
J Neurooncol; 2022 Jan; 156(1):195-204. PubMed ID: 34846639
[TBL] [Abstract][Full Text] [Related]
29. India's First Proton Beam Therapy Pediatric Patient.
Tonse R; Noufal MP; Deopujari CE; Jalali R
Neurol India; 2020; 68(1):189-191. PubMed ID: 32129277
[TBL] [Abstract][Full Text] [Related]
30. 20-year experience in childhood craniopharyngioma.
Hetelekidis S; Barnes PD; Tao ML; Fischer EG; Schneider L; Scott RM; Tarbell NJ
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):189-95. PubMed ID: 8407391
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
[TBL] [Abstract][Full Text] [Related]
32. Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma.
Toussaint L; Indelicato DJ; Muren LP; Li Z; Lassen-Ramshad Y; Kirby K; Pedro C; Mikkelsen R; Di Pinto M; Høyer M; Stokkevåg CH
Radiother Oncol; 2020 Jan; 142():140-146. PubMed ID: 31472997
[TBL] [Abstract][Full Text] [Related]
33. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital.
Fitzek MM; Linggood RM; Adams J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1348-54. PubMed ID: 16580494
[TBL] [Abstract][Full Text] [Related]
34. Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.
Bolsi A; Placidi L; Pica A; Ahlhelm FJ; Walser M; Lomax AJ; Weber DC
Radiother Oncol; 2020 Aug; 149():197-204. PubMed ID: 32387488
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical outcomes following treatment of childhood craniopharyngioma.
Winkfield KM; Tsai HK; Yao X; Larson E; Neuberg D; Pomeroy SL; Ullrich NJ; Cohen LE; Kieran MW; Scott RM; Goumnerova LC; Marcus KJ
Pediatr Blood Cancer; 2011 Jul; 56(7):1120-6. PubMed ID: 21488157
[TBL] [Abstract][Full Text] [Related]
36. Pediatric symptomatic Rathke cleft cyst compared with cystic craniopharyngioma.
Hayashi Y; Kita D; Fukui I; Sasagawa Y; Oishi M; Okajima M; Tachibana O; Nakada M
Childs Nerv Syst; 2016 Sep; 32(9):1625-32. PubMed ID: 27392448
[TBL] [Abstract][Full Text] [Related]
37. Management of recurrent craniopharyngioma.
Caldarelli M; di Rocco C; Papacci F; Colosimo C
Acta Neurochir (Wien); 1998; 140(5):447-54. PubMed ID: 9728244
[TBL] [Abstract][Full Text] [Related]
38. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
Yeung D; McKenzie C; Indelicato DJ
Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
[TBL] [Abstract][Full Text] [Related]
39. Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32.
Kumar PP; Good RR; Skultety FM; Jones EO; Chu WK
J Natl Med Assoc; 1986 Jun; 78(6):542-3, 547-9. PubMed ID: 3735454
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic, image-guided, transnasal instillation of (32)P for recurrent infrachiasmatic cystic craniopharyngioma.
Floyd JR; Cmelak A; Russell P; Weaver KD
Minim Invasive Neurosurg; 2009 Jun; 52(3):137-40. PubMed ID: 19650017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
